The Ministry of Health has published EBOLA DRC - Evolution of the response to the Ebola outbreak in the provinces of North Kivu and Ituri on Wednesday, March 13, 2019. Excerpt from the Google translation:
EPIDEMIOLOGICAL SITUATION IN THE PROVINCES OF NORTH KIVU AND ITURI
Wednesday, March 13, 2019
The epidemiological situation of the Ebola Virus Disease dated March 12, 2019:
• Since the beginning of the epidemic, the cumulative number of cases is 927, of which 862 are confirmed and 65 are probable. In total, there were 584 deaths (519 confirmed and 65 probable) and 308 people healed.
• 193 suspected cases under investigation;
• 2 new confirmed cases, including 1 in Mandima and 1 in Kalunguta;
• No new confirmed case deaths.
/! \ The data presented in this table are subject to change later, after extensive investigations and after redistribution of cases and deaths in their health areas.
News of the response
• Vaccination
Since vaccination began on August 8, 2018, 87,668 people have been vaccinated , including 22,275 in Katwa, 20,839 in Beni, 10,908 in Butembo, 6,109 in Mabalako, 2,935 in Kalunguta, 2,643 in Goma, 2,413 in Mandima, 2,317 in Komanda, 2,084 at Oicha, 1,389 at Kyondo, 1,357 at Karisimbi, 1,340 at Kayina, 1,315 at Bunia, 1,109 at Masereka, 1,064 at Vuhovi, 920 at Lubero, 772 at Mutwanga, 767 at Biena, 706 at Musienene, 690 at Rutshuru, 527 in Nyankunde, 519 in Rwampara (Ituri), 496 in Mangurujipa, 355 in Tchomia, 333 in Lolwa, 280 in Mambasa, 254 in Alimbongo, 250 in Mweso, 224 in Kibirizi, 207 in Kirotshe, 161 in Nyiragongo, 97 in Watsa (Haut-Uélé) and 13 in Kisangani.
• The only vaccine to be used in this outbreak is the rVSV-ZEBOV vaccine, manufactured by the pharmaceutical group Merck, following approval by the Ethics Committee in its decision of 19 May 2018.
